Ear and Nasal Packing Market Share

  • Report ID: 4035
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Ear and Nasal Packing Market Share

North American Market Forecast

North America industry is estimated to dominate majority revenue share of 35% by 2037. The major factor for market growth in the region is the increasing incidences of ear and nose disorders, such as sinus in the region. According to the data from the Centers for Disease Control and Prevention, in the United States, 11.6% of adults were diagnosed with sinusitis in 2020. Moreover, people have easier access to better healthcare facilities, backed by favorable medical reimbursement policies by the government and regulatory bodies which is also estimated to create favorable opportunities for market growth during the assessment period.  Further, the presence of a strong healthcare network in the region, with the availability of supportive policies along with the region's expanding healthcare industry and the increasing adoption of healthcare quality management are also anticipated to boost market growth during the forecast period.

Europe Market Forecast

The European ear and nasal packing market are estimated to be the second largest, registering a share of about 24% by the end of 2037. The burgeoning geriatric population who are more prone to ear and nasal diseases in the body and the presence of a large pool of patients in the region are majorly contributing positively to market growth. In addition to other factors, the expansion of ASEAN and Japan digital advertising in pharma and medical equipment is also estimated to increase the awareness level of ear and nasal illnesses and ear and nasal packing among the population and aid the expansion of the market in the region.

Further, the market in the European region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2037. The factors that are expected to contribute positively to market expansion in the region are rising research and development activities along with the proven success in the development of ear and nasal packing as an efficient treatment method. In addition, the rising prevalence of various types of chronic ear, nose, and throat diseases and disorders among the European people is also estimated to create a favorable outlook for market growth during the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4035
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ear and nasal packing is assessed at USD 266.63 million.

The ear and nasal packing market size was valued at USD 244.63 million in 2024 and is likely to cross USD 490.67 million by 2037, registering more than 5.5% CAGR during the forecast period i.e., between 2025-2037. The increasing demand for minimally invasive surgeries along with the rising cases of ENT problems will fuel the market growth.

North America industry is estimated to dominate majority revenue share of 35% by 2037, driven by increasing incidences of ear and nose disorders, such as sinus in the region.

The major players in the market are Stryker Corporation, Cerecor, Inc., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Smith & Nephew plc, Amgen Inc., Novartis AG, Bayer AG, Progenity, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample